Concepedia

Krishna Menon

KM

Statistics

Publications

6

Citations

195

H-Index

6

Active since

1996

Affiliations

Eli Lilly (United States)(Current)

Cambridge Scientific (United States)

Krishna Menon is an author at Eli Lilly (United States) specializing in oncology, molecular oncology, and pharmacology.

Publications per year

1996–2020

6

Publications

6

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

Beverly A. Teicher, Sylvia A. Holden, Gulshan Ara et al. · Cancer Chemotherapy and Pharmacology · 1996 · 72 citations

, , +12

Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.

Teicher Ba, Krishna Menon, Enrique Álvarez et al. · PubMed · 2002 · 35 citations

, , +14

Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth

Timothy J. Jorgensen, Hui Tian, Ingrid B.J. Joseph et al. · Cancer Chemotherapy and Pharmacology · 2006 · 34 citations

, , +17

Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.

Beverly A. Teicher, Krishna Menon, Enrique Álvarez et al. · PubMed · 2002 · 20 citations

, , +14

The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: Assessment of receptor contribution

Beverly A. Teicher, Hans-Peter Biemann, George Vande Woude et al. · International Journal of Oncology · 2008 · 18 citations · Full text

, , +7

1–5 of 6